We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Automated, Compact, Random Access Chemistry Analyzer Featured at AACC

By LabMedica International staff writers
Posted on 18 Jul 2012
Print article
Image: Indiko chemical analyzer (Photo courtesy of Thermo Scientific).
Image: Indiko chemical analyzer (Photo courtesy of Thermo Scientific).
AACC 2012: An automated, compact, random access chemistry analyzer is a cost-effective system designed for clinical chemistry and specialty testing.

Called Indiko, the Thermo Scientific (Waltham, MA, USA) chemical analyzer is being showcased at the 2012 annual conference of the American Association for Clinical Chemistry (AACC) Expo held at the Los Angeles Convention Center from July 15-19, 2012.

The benchtop analyzer is designed for routine clinical chemistry testing in small laboratory settings and specialty testing such as specific proteins, drug of abuse testing, and therapeutic drug monitoring including immunosuppressant drug monitoring (ISD).
A mix of bar-coded primary tubes and sample cups increase the flexibility of any operation. Patient oriented testing produces results quickly thus improving the quality of patient care.

With a small footprint, the Indiko analyzer fits ideally in a laboratory with space limitations. The graphical design of the user interface is supported by a touch screen.

Indiko includes several automated features, such as advanced dilution management and real-time monitoring of reagent usage, which help to manage a daily workload fluently. Samples, reagents, and consumables can continuously be loaded without interrupting the testing process, and different sample types can be analyzed at the same time.

A real-time QC program with multiple Westgard Rules assures the reliable performance. Application data as well as calibrator and control values are loadable from a file or from a two-dimensional barcode by the barcode scanner. The test flow definition allows for up to four reagent additions in each test, offering automation even for the most complex methods. The special cuvette design supports low reagent volumes thus reducing operating costs, especially important when working with specialty tests. Each cuvette is used only once to ensure accurate and precise results.

Related Links:
Thermofisher Scientific


New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
New
Gold Member
Chagas Disease Test
CHAGAS Cassette
New
Malaria Rapid Test
ASSURE Malaria P.f/P.v Rapid Test
New
Cryptosporidium Infection Test
Crypto (Card) Rapid Test

Print article

Channels

Molecular Diagnostics

view channel
Image: Umbilical cord blood biomarkers may improve preterm infant care (Photo courtesy of Shutterstock)

Umbilical Cord Blood Test Could Identify Preterm Infants at Risk for Medical Complications

Advancements in medical technology and neonatology have significantly improved the care of prematurely born infants. However, these infants still face heightened risks for medical complications, such as... Read more

Immunology

view channel

3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response

Tumor heterogeneity presents a major obstacle in the development and treatment of cancer therapies, as patients' responses to the same drug can differ, and the timing of treatment significantly influences prognosis. Consequently, technologies that predict the effectiveness of anticancer treatments are essential in minimizing... Read more

Microbiology

view channel
Image: The Cytovale System isolates, images, and analyzes cells (Photo courtesy of Cytovale)

Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Sepsis is the leading cause of death and the most expensive condition treated in U.S. hospitals. The risk of death from sepsis increases by up to 8% for each hour that treatment is delayed, making early... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.